CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 2, randomized, multicenter study in adult and adolescent participants with asthma and type 2 inflammation...
Phase 2
Baytown, Texas, United States and 57 other locations
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...
Phase 3
Houston, Texas, United States and 66 other locations
The objective of this study is to assess the potential for GB-0895 treatment to improve the health of adolescents and adults with severe asthma...
Phase 3
Sugar Land, Texas, United States and 58 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Cypress, Texas, United States and 65 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Houston, Texas, United States and 335 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Houston, Texas, United States and 142 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Houston, Texas, United States and 70 other locations
The primary purpose of this study is to evaluate the long-term safety and efficacy of verekitug (UPB-101) in participants who complete the VALIANT st...
Phase 2
Houston, Texas, United States and 101 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Houston, Texas, United States and 133 other locations
Phase 2 Dose Ranging Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) Over a 12-Week Treatment Period in Patients With Severe Asthma...
Phase 2
Houston, Texas, United States and 14 other locations
Clinical trials
Research sites
Resources
Legal